|
- Management of Squamous Cell Carcinoma Involving the Temporal Bone
Patient outcomes are improved by a combination of surgery and postoperative radiotherapy Preoperative imaging with high resolution CT and MRI is useful, particularly if there is evidence of large nerve perineural spread and nodal disease
- Temporal treatment bone squamous cell carcinoma: A change in
Surgical resection was deployed as the treatment for all the patients, followed by radiotherapy with or without chemotherapy LTBR was performed on patients with T1 and T2 lesions, whereas STBR was performed in T3 and T4 lesions (Figure 1A) The median age for this case series was aged 50 years with a male predominance
- Guidelines for Treating Temporal Bone Carcinoma Based on Long-Term Outcomes
Surgery with or without adjuvant radiotherapy is considered the stan-dard of care in the treatment of TBSCC Up until the middle of the 20th century, radical mastoidectomy was the surgical treatment of choice for malignancies of the temporal bone
- Malignant Tumors of the Temporal Bone - Medscape
The most common type of primary cancer in the EAC is squamous cell carcinoma, and squamous cell carcinoma of the temporal bone may originate from the EAC or middle ear where
- Tumours of Temporal Bone - Diagnosis, Management, and Advances in Treatment
Treatment involves surgical management: lateral temporal bone resection for tumours lateral to the tympanic membrane, extended temporal bone resection for advanced disease (often requiring facial nerve sacrifice and dura brain resection), and neck dissection for node-positive disease
- Cancer of the Temporal Bone - Ento Key
It is becoming increasingly clear that early aggressive surgical resection with adjuvant radiotherapy is important to maximize each patient’s outcome However, such resections and treatment are major undertakings and need to be considered carefully in the clinical context
- Squamous cell carcinoma of the temporal bone: A current review
Temporal bone resection with parotidectomy and neck dissection is the current standard of care Survival is generally good for early disease and poor for advanced disease, but chemotherapy is emerging as a promising treatment option Auditory rehabilitation with osseointegrated hearing aids is recommended at initial oncologic resection
- Squamous cell carcinoma of the temporal bone: A current review
Given the paucity of temporal bone malignancies, there are few large-scale studies and meta-analyses, no clinical trials, and substantially vari-able institutional management practices for TBSCC As such, optimal treatment for the disease remains elusive
|
|
|